EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells

Roberta F Chiavetta iD, Simona Titoli, Viviana Barra iD, Patrizia Cancemi iD, Raffaella Melfi iD, Aldo Di Leonardo iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Roberta F Chiavetta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, 90128 Palermo, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Ricerca Fibrosi Cistica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is reported that about 10% of cystic fibrosis (CF) patients worldwide have nonsense (stop) mutations in the CFTR gene, which cause the premature termination of CFTR protein synthesis, leading to a truncated and non-functional protein. To address this issue, we investigated the possibility of rescuing the CFTR nonsense mutation (UGA) by sequence-specific RNA editing in CFTR mutant CFF-16HBEge, W1282X, and G542X human bronchial cells. We used two different base editor tools that take advantage of ADAR enzymes (adenosine deaminase acting on RNA) to edit adenosine to inosine (A-to-I) within the mRNA: the REPAIRv2 (RNA Editing for Programmable A to I Replacement, version 2) and the minixABE (A to I Base Editor). Immunofluorescence experiments show that both approaches were able to recover the CFTR protein in the CFTR mutant cells. In addition, RT-qPCR confirmed the rescue of the CFTR full transcript. These findings suggest that site-specific RNA editing may efficiently correct the UGA premature stop codon in the CFTR transcript in CFF-16HBEge, W1282X, and G542X cells. Thus, this approach, which is safer than acting directly on the mutated DNA, opens up new therapeutic possibilities for CF patients with nonsense mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisHumansRNA, MessengerRNA EditingMutationCell LineCodon, Terminator

Stichwörter der Autor:innen

CRISPR/dCas13REPAIRv2RNA editingcystic fibrosismxABEpremature termination codons (PTCs)

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorRNA, MessengerCodon, TerminatorCFTR protein, human

Autor:innen und Institutionen

  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, 90128 Palermo, Italy.
  • Centro di Oncobiologia Sperimentale (C.O.B.S.), Viale Delle Scienze, 90128 Palermo, Italy.

ORCID-Profile: Roberta F Chiavetta, Viviana Barra, Patrizia Cancemi, Raffaella Melfi, Aldo Di Leonardo

Förderung

  • Fondazione Ricerca Fibrosi Cistica

Zitieren

APA

Chiavetta, R. F., Titoli, S., Barra, V., Cancemi, P., Melfi, R., & Di Leonardo, A. (2023). Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310940

Vancouver

Chiavetta RF, Titoli S, Barra V, Cancemi P, Melfi R, Di Leonardo A. Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310940

BibTeX
@article{Chiavetta2023,
  author = {Chiavetta, Roberta F and Titoli, Simona and Barra, Viviana and Cancemi, Patrizia and Melfi, Raffaella and Di Leonardo, Aldo},
  title = {Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310940}
}
Kostenlos starten →